| Address:
|
ONE MERCK DR
P O BOX 100 |
| City: |
WHITEHOUSE STATION |
|
State: |
NJ |
|
Zip Code: |
08889-0100 |
| Telephone: |
908-423-1688 |
|
Description of Business
|
Primary SIC Code:
2834 |
| (As filed with the SEC)
|
|
|
Merck & Co., Inc. ("Merck" or the "Company") is a global research-driven
pharmaceutical company that discovers, develops, manufactures and markets a
broad range of innovative products to improve human and animal health. The
Company's operations are principally managed on a products basis and are
comprised of two reportable segments: the Pharmaceutical segment and the
Vaccines segment. The Pharmaceutical segment includes human health
pharmaceutical products marketed either directly or through joint ventures.
These products consist of therapeutic and preventive agents, sold by
prescription, for the treatment of human disorders. Merck sells these human
health pharmaceutical products primarily to drug wholesalers and retailers,
hospitals, government agencies and managed health care providers such as health
maintenance organizations, pharmacy benefit managers and other institutions. ... More ... |
| Date |
12-mos
Rolling EPS |
Dividend |
P/E
Ratio |
| 03/2009 | 2.79 | 0.380 | 9.59 | | 12/2008 | 3.64 | 0.380 | 8.35 | | 09/2008 | 2.11 | 0.380 | 14.96 | | 06/2008 | 2.28 | 0.380 | 16.53 | | 03/2008 | 2.23 | 0.380 | 17.02 | | 12/2007 | 1.49 | 0.380 | 39.00 | | 09/2007 | 2.46 | 0.380 | 21.01 | | 06/2007 | 2.20 | 0.380 | 22.64 |
Key Financial Ratios and Statistics |
FYE:
12/31 |
| Profitability |
2008 |
Leverage |
2008 |
| Net Inc/Comm Equity | -0.35 | Total Liab/Total Assets | 0.60 | | Net Inc/Total Assets | 0.17 | Total Liab/Inv Cap | 0.93 | | Net Inc/Inv Cap | 0.26 | Total Liab/Comm Equity | -1.27 | | Pretax Inc/Net Sales | 0.41 | Interest Coverage Ratio | 40.03 | | Net Inc/Net Sales | 0.33 | Curr Debt/Equity | 0.12 | | Cash Flow/Net Sales | 0.28 | LTD/Equity | 0.21 | | SG&A/NetSales | 0.31 | Total Debt/Equity | 0.33 |
| Asset Utilization
|
|
Liquidity |
|
| Net Receivables Turnover | 3.14 | Quick Ratio | 1.19 | | Inventory Turnover | 2.68 | Current Ratio | 1.35 | | Inventory Day Sales | 0.01 | Net Rec/Curr Assets | 0.60 | | Net Sales/Work Cap | 4.78 | Inv/Curr Assets | 0.12 | | Net Sales/PP&E | 1.99 | | |
Income Statement (Millions) |
| |
3/31/2009
|
12/31/2008
|
9/30/2008
|
6/30/2008
|
|
Total Revenues(Net Sales)
|
5,385.20
|
6,032.40
|
5,944.00
|
6,051.80
|
|
Cost of Goods Sold
|
1,333.80
|
1,470.00
|
1,477.90
|
1,396.50
|
|
Selling & Admin Exps
|
1,632.90
|
1,862.00
|
1,730.30
|
1,930.30
|
|
Operating Income
|
1,130.00
|
1,210.70
|
807.20
|
1,453.50
|
|
Interest Exp
|
60.70
|
56.70
|
71.40
|
50.60
|
|
Pretax Income
|
1,783.00
|
1,927.40
|
1,411.00
|
2,058.40
|
|
Other Income
|
127.90
|
-40.40
|
40.70
|
163.40
|
|
Net Income Bef Extraordinary ...
|
NA
|
NA
|
NA
|
NA
|
|
Net Income
|
1,455.80
|
1,644.80
|
1,092.80
|
1,768.20
|
|
Assets
|
3/31/2009
|
12/31/2008
|
9/30/2008
|
6/30/2008
|
|
Cash & Short Term Investments
|
12,581.60
|
5,486.40
|
6,841.30
|
9,987.50
|
|
Receivables - Total
|
11,475.20
|
11,535.20
|
10,349.00
|
3,647.00
|
|
Inventories - Total
|
2,127.80
|
2,283.30
|
2,228.20
|
2,190.60
|
|
Total Current Assets
|
26,184.60
|
19,304.90
|
19,418.50
|
17,592.90
|
|
Net Property, Plant & Equipment
|
12,500.40
|
11,999.60
|
12,518.80
|
12,240.40
|
|
Total Assets
|
46,543.10
|
47,195.70
|
48,545.70
|
47,457.50
|
|
Liabilities
|
|
|
|
|
|
Accounts Payable
|
10,534.10
|
12,021.60
|
11,434.10
|
8,537.30
|
|
Debt in Current Liabilities
|
2,881.80
|
2,297.10
|
2,994.20
|
1,181.30
|
|
Total Current Liabilities
|
13,415.90
|
14,318.70
|
14,428.30
|
9,718.60
|
|
Long-Term Debt
|
3,939.10
|
3,943.30
|
3,938.80
|
3,932.40
|
|
Total Liabilities
|
26,980.10
|
28,437.40
|
28,974.70
|
27,201.50
|
|
Stockholder's Equity
|
|
|
|
|
|
Minority Interest
|
2,438.50
|
2,408.80
|
2,439.70
|
2,410.10
|
|
Preferred Stock
|
NA
|
NA
|
NA
|
NA
|
|
Common Stock
|
29.80
|
29.80
|
29.80
|
29.80
|
|
Retained Earnings
|
44,320.40
|
43,698.80
|
42,857.30
|
42,573.20
|
|
Treasury Stock
|
-30,701.20
|
-30,735.50
|
-30,552.00
|
-29,599.80
|
|
Total Stockholders' Equity
|
19,563.00
|
18,758.30
|
19,571.00
|
20,256.00
|
|
Total Liabilities and Stockholders' Equity
|
46,543.10
|
47,195.70
|
48,545.70
|
47,457.50
|
Cash Flow Summary (Millions) |
|
Categories
|
3/31/2009
|
12/31/2008
|
9/30/2008
|
6/30/2008
|
|
Net Cash Provided by Operating Activities
|
712.60
|
1,010.80
|
1,652.00
|
1,380.60
|
|
Net Cash Provided by Investing Activities
|
1,390.10
|
-450.20
|
-3,278.00
|
-9.00
|
|
Net Cash Provided by Financing Activities
|
-391.90
|
-1,755.40
|
104.60
|
-288.10
|
Annual Summary Data (Millions) |
| Year |
Sales |
Net
Income |
EPS |
| 12/2004 | 22,938.60 | 5,813.40 | 2.61 | | 12/2005 | 22,011.90 | 4,631.30 | 2.10 | | 12/2006 | 22,636.00 | 4,433.80 | 2.03 | | 12/2007 | 24,197.70 | 3,275.40 | 1.49 | | 12/2008 | 23,850.30 | 7,808.40 | 3.64 | | Growth Rates | 0.98 | 7.65 | 8.67 |
| Type |
Date(Q,M) |
No.
Owners |
Shares
Held (000s) |
%
Own |
| Institutional | 03/31/09 | 1155 | 1,540,903 | 73.09 |
|
Report Date :
6/23/2009
 Copyright
2009, EDGAR Online, Inc. All
rights reserved. Replication or redistribution of EDGAR Online, Inc. content is
expressly prohibited without the prior written consent of EDGAR Online, Inc.
EDGAR Online, Inc. shall not be liable for any errors or delays in the content,
or for any actions taken in reliance thereon.
|
|
|